Galenix combines, around 2 platforms -an early development site and a cGMP Europe and US FDA site-, a full integrated pharmaceutical services offer in:

• Drug Product Development services (including sourcing of the API/ qualification, pre-formualtion, formulation of the drug product, analytical development and validation, scale-up on industrial site, registration of MA...
• Clinical Supplies with pilot and clinical trial batches manufacturing, packaging and distribution, QP release...
• Drug Delivery Solutions with 6 patented technologies available for the licensing out to improve biovailibility and/or stability and/or the Patient compliance: 
  • Minextab® and Minextab® Floating for high content of API
  • Microgix® for chemical or biological entities
  • Mucolys® Film and Mucolys® Flash for buccal administration
  • ODTx® orodispersible tablet

Galenix is a high value-partner for:

• Research contract,
• Feasibility contract,
• Drug Product Development and Full Pharmaceutical Services contract,
• Manufacturing, packaging and distribution contract

Galenix's market:
Big Pharma companies located in the US, others in Europe and in Japan.

With its full service offer and its genuine Drug Delivery Systems, GALENIX is a high value partner to pharmaceutical companies looking into boosting their sales on Rx, generic or OTC products in a Life Cycle Management process. For this, the company has undertaken strong marketing and sales actions, especially in the US and Japan through exhibitions, face to face meetings and congresses.